NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 4,890.00
+390.00 (8.67%)
At close: Sep 3, 2026
NovMetaPharma Market Cap
NovMetaPharma has a market cap or net worth of 64.02 billion as of September 4, 2026. Its market cap has decreased by -64.26% in one year.
Market Cap
64.02B
Enterprise Value
n/a
Revenue
1.30B
Ranking
n/a
PE Ratio
41.54
Stock Price
4,890.00
ChartMarket Cap Chart
Since April 5, 2017, NovMetaPharma's market cap has decreased from 74.59B to 64.02B, a decrease of -14.18%. That is a compound annual growth rate of -1.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 64.02B | -60.89% |
| Dec 30, 2025 | 163.69B | 187.16% |
| Dec 30, 2024 | 57.00B | -46.33% |
| Dec 29, 2022 | 106.21B | -45.89% |
| Dec 30, 2021 | 196.29B | -9.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AriBioLab | 72.70B |
| ADBiotech | 68.59B |
| PanGen Biotech | 67.17B |
| Psomagen | 66.17B |
| Naturalendo Tech | 65.67B |
| ABION | 60.91B |
| TegoScience | 60.61B |
| J2KBIO | 59.70B |